Administrative Core (Core A)
Administrative Core (Core A)
批准号:
10576277
负责人:
Thomas William Geisbert
金额:
$20.25万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-03-08 至 2025-02-28
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT – Core A, Administrative Core
The Administrative Core is responsible for the overall management and coordination of the Center of Excellence
for Translational Research (CETR) for “Advancement of Vaccines and Treatments for Ebola and Marburg Virus
Infections”. It provides governance, financial oversight, and operational management functions to facilitate the
execution of the overall research plan, thereby enabling the CETR to fulfill its mission to develop postexposure
treatments for Ebola and Marburg hemorrhagic fever. The Administrative Core will provide an organizational and
programmatic structure to promote research productivity and synergy through scientific interactions. The Core
will provide oversight in setting CETR priorities, including decision-making processes involving the continual
evaluation of research and product development. Core personnel will ensure that the CETR is compliant with
issues involving the use of vertebrate animals and human subjects, and ensure that regulatory expertise is
available for associated translational activities. Management activities are carried out with the advice of the
Scientific Advisory Committee in close collaboration with NIAID’s biodefense program administrators.
Teleconferencing is maximally utilized to facilitate communication between the University of Texas Medical
Branch, the lead institution for the CETR, and other participating institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of novel Henipavirus inhibitors
-
批准号:10845863
-
项目类别:
-
资助金额:$231.77万
-
财政年份:2022
-
负责人:Thomas William Geisbert
-
依托单位:
Discovery of novel Henipavirus inhibitors
-
批准号:10514154
-
项目类别:
-
资助金额:$529.18万
-
财政年份:2022
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical development of a vaccine for Nipah virus
-
批准号:10214949
-
项目类别:
-
资助金额:$141.6万
-
财政年份:2021
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical development of a vaccine for Nipah virus
-
批准号:10369731
-
项目类别:
-
资助金额:$117.98万
-
财政年份:2021
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical development of a vaccine for Nipah virus
-
批准号:10576335
-
项目类别:
-
资助金额:$115.9万
-
财政年份:2021
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
-
批准号:10217000
-
项目类别:
-
资助金额:$64.23万
-
财政年份:2020
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
-
批准号:10655324
-
项目类别:
-
资助金额:$73.99万
-
财政年份:2020
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
-
批准号:10440280
-
项目类别:
-
资助金额:$74.0万
-
财政年份:2020
-
负责人:Thomas William Geisbert
-
依托单位:
Core C - The University of Texas Medical Branch at Galveston
-
批准号:10362729
-
项目类别:
-
资助金额:$80.23万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections
-
批准号:9889877
-
项目类别:
-
资助金额:$733.94万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections
-
批准号:10356834
-
项目类别:
-
资助金额:$704.32万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Administrative Core (Core A)
-
批准号:10564148
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
BSL-4 Evaluation Core (Core B)
-
批准号:10564149
-
项目类别:
-
资助金额:$283.42万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Research Project 3: siRNA Therapy and Small Molecule Combination Treatment for Filoviruses
-
批准号:10576281
-
项目类别:
-
资助金额:$72.36万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Research Project 3: siRNA Therapy and Small Molecule Combination Treatment for Filoviruses
-
批准号:10564152
-
项目类别:
-
资助金额:$66.39万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Core C - The University of Texas Medical Branch at Galveston
-
批准号:10581495
-
项目类别:
-
资助金额:$253.87万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections
-
批准号:10576276
-
项目类别:
-
资助金额:$704.32万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
BSL-4 Evaluation Core (Core B)
-
批准号:10576278
-
项目类别:
-
资助金额:$289.09万
-
财政年份:2019
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
-
批准号:9363104
-
项目类别:
-
资助金额:$134.53万
-
财政年份:2017
-
负责人:Thomas William Geisbert
-
依托单位:
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
-
批准号:10179308
-
项目类别:
-
资助金额:$110.47万
-
财政年份:2017
-
负责人:Thomas William Geisbert
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
-
批准号:82371765
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:谭广云
-
依托单位:
锕系元素5f-in-core的GTH赝势和基组的开发
-
批准号:22303037
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:鲁俊波
-
依托单位:
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
-
批准号:--
-
项目类别:--
-
资助金额:52万元
-
批准年份:2022
-
负责人:孙丙军
-
依托单位:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:叶成林
-
依托单位:
基于外泌体精准调控的“核-壳”(core-shell)同步血管化骨组织工程策略的应用与机制探讨
-
批准号:--
-
项目类别:--
-
资助金额:55万元
-
批准年份:2020
-
负责人:张智勇
-
依托单位:
基于外泌体精准调控的“核-壳”(core-shell)同步血管化骨组织工程策略的应用与机制探讨
-
批准号:82072415
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:张智勇
-
依托单位:
肌营养不良蛋白聚糖Core M3型甘露糖肽的精确制备及功能探索
-
批准号:92053110
-
项目类别:重大研究计划
-
资助金额:70.0万元
-
批准年份:2020
-
负责人:彭鹏
-
依托单位:
Core-1-O型聚糖黏蛋白缺陷诱导胃炎发生并介导慢性胃炎向胃癌转化的分子机制研究
-
批准号:81902805
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:刘菲
-
依托单位:
原始地球增生晚期的Core-merging大碰撞事件:地核增生、核幔平衡与核幔边界结构的新认识
-
批准号:41973063
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:周游
-
依托单位:
CORDEX-CORE区域气候模拟与预估研讨会
-
批准号:41981240365
-
项目类别:国际(地区)合作与交流项目
-
资助金额:1.5万元
-
批准年份:2019
-
负责人:陈威霖
-
依托单位: